Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial Eliot N. Mostow,

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

In search of optimal compression therapy for venous leg ulcers: A meta-analysis of studies comparing divers bandages with specifically designed stockings

Conservative versus surgical treatment of venous leg ulcers: A prospective, randomized, multicenter trial Wijnand B. van Gent, MD, Wim C. Hop, PhD, Marinus.

Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: A randomized, controlled, multicenter study Stefan Beckert, MD,

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers David L. Steed, MD, the.

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications

State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Without prejudice Journal of Vascular Surgery

Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk John A. Sandoval,

Conservative versus surgical treatment of venous leg ulcers: A prospective, randomized, multicenter trial Wijnand B. van Gent, MD, Wim C. Hop, PhD, Marinus.

International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results Jon S. Matsumura,

The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and.

Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers William Marston, MD, Daniel Fish,

Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M

Peter J. Fahner, MD, Mirza M. Idu, MD, PhD, Thomas M

Postthrombotic or non-postthrombotic severe venous insufficiency: Impact of removal of superficial venous reflux with or without subcutaneous fasciotomy

Society for Vascular Surgery® (SVS)—The beginning

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia Louis L. Nguyen,

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

In search of optimal compression therapy for venous leg ulcers: A meta-analysis of studies comparing divers bandages with specifically designed stockings

Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers Eugenio Brizzio, MD, Felix Amsler, MS,

Comparison of low-strength compression stockings with bandages for the treatment of recalcitrant venous ulcers Eugenio Brizzio, MD, Felix Amsler, MS,

State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings

A randomized trial of the Tubulcus multilayer bandaging system in the treatment of extensive venous ulcers Dragan J. Milic, PhD, Sasa S. Zivic, MD, Dragan.

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010 Grant H. Skrepnek, PhD, David G. Armstrong,

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Ali F. AbuRahma, MD Journal of Vascular Surgery

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD

Louis L. Nguyen, MD, MBA, MPH Journal of Vascular Surgery

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Elsie Gyang, MD, MSc, Mohamed Zayed, MD, PhD, E

The first operation on the profunda femoris artery

Without prejudice Journal of Vascular Surgery

Regulatory TEVAR clinical trials

Infected aneurysm of the thoracic aorta

Split-thickness skin grafting the high-risk diabetic foot

Selective application of sartorius muscle flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic graft.

Paul Berger, MD, Dennis de Bie, MaNP, Frans L

The natural history of untreated severe or critical limb ischemia

The future of vascular surgery

Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications

Manjit S. Gohel, MB, MRCS, Robin A. J. Windhaber, MSc, MRCS, John F

Reply Journal of Vascular Surgery

Chung-Dann Kan, MD, Hsin-Ling Lee, MD, Yu-Jen Yang, MD, PhD

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Psoas abscess in patients with an infected aortic aneurysm

Soma Brahmanandam, MD, MPH, Eric L. Ding, ScD, Michael S

Current treatment of renal artery aneurysms may be too aggressive

Reviewer Acknowledgment

Unknown pages in the history of vascular stent grafting

Glauco Milio, MD, Chiara Minà, MD, Valentina Cospite, MD, Piero L

Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: A randomized, controlled, multicenter study Stefan Beckert, MD,

Regarding “Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results” John B. Chang, MD,

Branding vascular surgery should start with Why

Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events Louis L. Nguyen,

Optimal exercise program length for patients with claudication

The care of the patient with vascular disease

Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R

Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk John A. Sandoval,

A census-based analysis of racial disparities in lower extremity amputation rates in Northern Illinois, Joe Feinglass, PhD, Shabir Abadin,

Patrick A. Stone, MD, Ali F. AbuRahma, MD, Sarah K. Flaherty, BS

Results of a single center vascular screening and education program

Recruiting participants with peripheral arterial disease for clinical trials: Experience from the Study to Improve Leg Circulation (SILC) Mary M. McDermott,

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Paul Berger, MD, Dennis de Bie, MaNP, Frans L

Clinical outcomes after closed, staged, and open forefoot amputations

Presentation transcript:

Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial Eliot N. Mostow, MD, MPH, G. Davin Haraway, DO, CWS, Michael Dalsing, MD, Jason P. Hodde, MS, Dennis King, PhD Journal of Vascular Surgery Volume 41, Issue 5, Pages 837-843 (May 2005) DOI: 10.1016/j.jvs.2005.01.042 Copyright © 2005 The Society for Vascular Surgery. Terms and Conditions

Fig 1 Patient flow through the clinical trial. Journal of Vascular Surgery 2005 41, 837-843DOI: (10.1016/j.jvs.2005.01.042) Copyright © 2005 The Society for Vascular Surgery. Terms and Conditions

Fig 2 Survival plot analysis for the small-intestine submucosa (SIS) wound matrix group and the standard-care group. Success was defined as 100% healing. Patients treated with SIS wound matrix were more likely to heal by 12 weeks than those in the standard-care group (P = .0226). Journal of Vascular Surgery 2005 41, 837-843DOI: (10.1016/j.jvs.2005.01.042) Copyright © 2005 The Society for Vascular Surgery. Terms and Conditions